Hillhouse Capital Advisors »

Aligos Therapeutics shares owned by Hillhouse Capital Advisors

Quarter-by-quarter ownership of Aligos Therapeutics shares owned by Hillhouse Capital Advisors from 13F filings

Historical chart of Hillhouse Capital Advisors investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by Hillhouse Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by Hillhouse Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $660k 76k 8.66

More positions owned by Hillhouse Capital Advisors

Beigene Sponsored Adr (BGNE)
Alibaba Group Hldg Sponsored Ads (BABA)
Pdd Holdings Sponsored Ads (PDD)
Legend Biotech Corp Sponsored Ads (LEGN)
Vipshop Hldgs Sponsored Ads A (VIPS)
Netease Sponsored Ads (NTES)
Ke Hldgs Sponsored Ads (BEKE)
Trip Com Group Ads (TCOM)
Arrivent Biopharma (AVBP)
Futu Hldgs Spon Ads Cl A (FUTU)
Zto Express Cayman Sponsored Ads A (ZTO)
Jd.com Spon Adr Cl A (JD)
Enfusion Cl A (ENFN)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Cytek Biosciences (CTKB)

View all positions for Hillhouse Capital Advisors

Top funds holding Aligos Therapeutics

Woodline Partners
Baker Bros. Advisors
Hillhouse Capital Advisors
Acadian Asset Management
Geode Capital Management
Renaissance Technologies
Charles Schwab Investment Management
BlackRock
Bank of America Corporation
CWM
Advisor Group Holdings
AlphaMark Advisors
Jpmorgan Chase & Co
Zrc Wealth Management
Bnp Paribas Arbitrage, Snc

View all funds holding Aligos Therapeutics